MARCH 2024 NEUROENDOCRINE CANCER UK QUARTERLY NEWSLETTER

WELCOME TO OUR 2024 SPRING NEWSLETTER

What a delight that Spring is finally here - longer days and more daylight is within reach! Here at Neuroendocrine Cancer UK it is the time when all our planning starts moving into active projects, and we have quite a few on the go. As an organisation we are constantly changing and evolving to try and meet the needs of all affected by neuroendocrine cancers. We have a strong focus this year on access to treatments and more

We have launched our most comprehensive patient information offering to date and ensuring that we have useful information for hospitals and clinics to utilise. We are driving our campaigns around HCP education and we have a new updated, expanded and improved training programme for nurses in progress. We are also taking some time to understand how people perceive us. We will be launching a survey shortly that we would be so grateful if you could complete. This survey will help us so much to stay on track, develop and grow to meet your requirements. conversations around the diversity of these cancers, more information about the different types of neuroendocrine cancers and reflecting this on an updated website that is being worked on now.

Every month we will be sharing our monthly roundups so you are fully informed, and we have some interesting podcasts to share this year so do look for those.

The support service have been working so hard to provide not only support but information in the form of the Webinatters. These are an amazing resource so please do sign up! We couldn’t do any of this without your support so thank you to each and everyone of you who has donated. We so appreciate it. I would also like to thank our Trustees for their time and expertise and we look forward to welcoming some new Trustees to the Board this year. We have a great group of Ambassadors that are such a vital part of our team, and this group has welcomed new members too - thank you all. I must also thank our advisory board and medical colleagues for the time they give to us. We know how precious their time is.

With that I hope this newsletter is interesting and helpful, and do know that we welcome feedback and ideas at any time.

See you soon, Cathy x

www.neuroendocrinecancer.org.uk

Made with FlippingBook flipbook maker